1.5 CE Total | 1.0 Pharm
In this webinar Dr. Anderson will review the latest science and clinical outcomes from years of clinical research in biofilm therapies. He will outline the difference between Phase-1 and Phase-2 biofilms, and how to assess and treat each part of that spectrum.
2.0 CE Total | 2.0 Pharm
In this webinar Dr. Anderson will review Pharmacy, Office Compounding, and In Office Use update – Rule changes from the FDA/USP and their effects on your office compounding practices.
3.0 CE Total | 1.0 Pharm
Anosmia, dysgeusia, headaches, neuropathies and more. Now that COVID has been with us for two years or more these associated issues are growing in our patient population. In this webinar DrA will review the data published recently regarding these issues, the underlying pathophysiology between the virus and the nervous system, and potential therapeutic approaches.